222 related articles for article (PubMed ID: 25823631)
1. The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review.
Bauer IE; Soares JC; Nielsen DA
Am J Addict; 2015 Jan; 24(1):15-23. PubMed ID: 25823631
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic treatments for drug addiction: alcohol and opiates.
Haile CN; Kosten TA; Kosten TR
Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of addiction to opioids and cocaine.
Saxon AJ; Oreskovich MR; Brkanac Z
Harv Rev Psychiatry; 2005; 13(4):218-32. PubMed ID: 16126608
[TBL] [Abstract][Full Text] [Related]
4. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of dual substance abuse and dependence.
Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
[TBL] [Abstract][Full Text] [Related]
6. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
[TBL] [Abstract][Full Text] [Related]
8. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients.
Thomas PS; Nielsen EM; Spellicy CJ; Harding MJ; Ye A; Patriquin M; Hamon SC; Kosten TR; Nielsen DA
Psychiatr Genet; 2021 Jun; 31(3):88-94. PubMed ID: 33953123
[TBL] [Abstract][Full Text] [Related]
9. Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.
Crist RC; Ambrose-Lanci LM; Vaswani M; Clarke TK; Zeng A; Yuan C; Ferraro TN; Hakonarson H; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Doyle GA; Lohoff FW; Berrettini WH
Drug Alcohol Depend; 2013 Jan; 127(1-3):122-8. PubMed ID: 22795689
[TBL] [Abstract][Full Text] [Related]
10. The specificity of family history of alcohol and drug abuse in cocaine abusers.
Compton WM; Cottler LB; Ridenour T; Ben-Abdallah A; Spitznagel EL
Am J Addict; 2002; 11(2):85-94. PubMed ID: 12028739
[TBL] [Abstract][Full Text] [Related]
11. A brief review of the genetics and pharmacogenetics of opioid use disorders.
Berrettini W
Dialogues Clin Neurosci; 2017 Sep; 19(3):229-236. PubMed ID: 29302220
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment.
Khokhar JY; Ferguson CS; Zhu AZ; Tyndale RF
Annu Rev Pharmacol Toxicol; 2010; 50():39-61. PubMed ID: 20055697
[TBL] [Abstract][Full Text] [Related]
13. Genes associated with addiction: alcoholism, opiate, and cocaine addiction.
Kreek MJ; Nielsen DA; LaForge KS
Neuromolecular Med; 2004; 5(1):85-108. PubMed ID: 15001815
[TBL] [Abstract][Full Text] [Related]
14. The opioid system in alcohol and drug dependence: family-based association study.
Xuei X; Flury-Wetherill L; Bierut L; Dick D; Nurnberger J; Foroud T; Edenberg HJ
Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):877-84. PubMed ID: 17503481
[TBL] [Abstract][Full Text] [Related]
15. Addiction pharmacotherapy 2000: new options, new challenges.
Rawson RA; McCann MJ; Hasson AJ; Ling W
J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of Addiction Therapy.
Graham DP; Harding MJ; Nielsen DA
Methods Mol Biol; 2022; 2547():437-490. PubMed ID: 36068473
[TBL] [Abstract][Full Text] [Related]
17. Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.
Yuferov V; Butelman ER; Randesi M; Ott J; Kreek MJ
Neurosci Lett; 2022 Jan; 768():136364. PubMed ID: 34843875
[TBL] [Abstract][Full Text] [Related]
18. Clinical uses of naltrexone: a review of the evidence.
Modesto-Lowe V; Van Kirk J
Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
[TBL] [Abstract][Full Text] [Related]
19. Current concepts in pharmacotherapy of substance abuse.
Gottschalk PC; Jacobsen LK; Kosten TR
Curr Psychiatry Rep; 1999 Dec; 1(2):172-8. PubMed ID: 11122921
[TBL] [Abstract][Full Text] [Related]
20. Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways.
Wu B; Hand W; Alexov E
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
